UTHSC Professor Receives Grant To Study Ormeloxifene As Prostate Cancer Treatment

UTHSC Professor Receives Grant To Study Ormeloxifene As Prostate Cancer Treatment
The U.S. Department of Defense will provide a $562,500 grant for Dr. Subhash Chauhan, a professor in the Department of Pharmaceutical Sciences in the College of Pharmacy at the University of Tennessee Health Science Center (UTHSC), to study ormeloxifene as a treatment for advanced prostate cancer. Originally a birth control drug, this selective estrogen receptor

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *